🏠 News Empire
health

Kerala Doubles Monthly Pension for Cancer, TB, and Leprosy Patients to ₹2,000

Published on: 23 Jul 2026, 02:17 PM
Kerala Doubles Monthly Pension for Cancer, TB, and Leprosy Patients to ₹2,000

The Kerala government has officially increased the monthly pension for patients suffering from cancer, leprosy, and tuberculosis (TB) from ₹1,000 to ₹2,000. The decision, announced in the state's Revised Budget for 2026-27, aims to provide greater financial support to those undergoing treatment for these serious illnesses.

According to a statement from Health Minister K. Muraleedharan, the enhanced pension is specifically for beneficiaries who fall under the Below Poverty Line (BPL) category. Eligible patients will receive the increased amount for the duration of their treatment, provided they submit a certificate issued by the Health Department verifying their condition.

The move is seen as a significant step in easing the financial burden on low-income families dealing with prolonged and expensive medical care. Cancer, tuberculosis, and leprosy often require extended treatment periods, which can strain household finances. By doubling the pension, the state government hopes to ensure that patients can focus on recovery without worrying about basic expenses.

The Revised Budget 2026-27, presented earlier this year, allocated additional funds for social welfare schemes, including this pension enhancement. The government has directed all relevant departments to implement the order promptly and ensure that eligible patients receive the benefits without delay.

Health experts have welcomed the initiative, noting that such financial assistance can improve treatment adherence and outcomes. The certificate requirement is intended to prevent misuse and ensure that only genuine patients benefit from the scheme.

The order is part of Kerala's broader commitment to universal healthcare and social security, reinforcing its reputation as a state with progressive welfare policies.

Latest in Health 10
Microplastic warning labels: FSSAI asks Madras HC to review order, cites inconclusive science
health

Microplastic warning labels: FSSAI asks Madras HC to review order, cites inconclusive science

The FSSAI has asked the Madras High Court to review an order mandating microplastic warning labels on bottled water, sugar, and salt, citing inconclusive scientific evidence and fears of public panic. The regulator has also flagged the lack of global regulations and the practical burden on food businesses. The review plea is scheduled for hearing on September 7, 2026.

The Hindu 06 Sep 2026, 01:48 PM
Read More →
→ View All Health News